JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDS
4926
Precision Drilling
PDS
$999M
| $177K | ﹤0.01% |
3,636
-3,107
| -46% | -$148K |
|
4927
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.85B
| $177K | ﹤0.01% |
2,154
-127
| -6% | -$10K |
|
4928
Grindr
GRND
$3.08B
| $176K | ﹤0.01% |
+31,801
| New | +$194K |
|
|
BHIL
4929
DELISTED
Benson Hill, Inc.
BHIL
| $176K | ﹤0.01% |
3,865
-1,725
| -31% | -$73.9K |
|
4930
Universal Technical Institute
UTI
$2.16B
| $176K | ﹤0.01% |
25,437
+64
| +0.3% | +$431 |
|
|
NOTE
4931
DELISTED
FiscalNote
NOTE
| $176K | ﹤0.01% |
4,023
+3,836
| +2,051% | +$108K |
|
4932
Medallion Financial
MFIN
$229M
| $175K | ﹤0.01% |
22,090
+8,516
| +63% | +$58.4K |
|
|
MBCN
4933
DELISTED
Middlefield Banc Corp
MBCN
| $174K | ﹤0.01% |
6,500
+6,477
| +28,161% | +$169K |
|
4934
Monte Rosa Therapeutics
GLUE
$1.4B
| $174K | ﹤0.01% |
25,428
+1,028
| +4% | +$6.65K |
|
4935
Parke Bancorp
PKBK
$401M
| $174K | ﹤0.01% |
10,238
+1,653
| +19% | +$27.7K |
|
4936
Kodiak Sciences
KOD
$2.6B
| $174K | ﹤0.01% |
25,148
-577
| -2% | -$3.53K |
|
|
ORTX
4937
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $173K | ﹤0.01% |
33,419
-14,806
| -31% | -$75.5K |
|
4938
Nathan's Famous
NATH
$402M
| $172K | ﹤0.01% |
2,194
-1,347
| -38% | -$101K |
|
4939
Fossil Group
FOSL
$293M
| $172K | ﹤0.01% |
67,006
+21,999
| +49% | +$60.5K |
|
4940
Matrix Service
MTRX
$326M
| $172K | ﹤0.01% |
29,176
-41,084
| -58% | -$225K |
|
|
IFN
4941
Aberdeen India Fund
IFN
$499M
| $172K | ﹤0.01% |
10,351
+10,343
| +129,288% | +$162K |
|
4942
BRC Inc
BRCC
$121M
| $172K | ﹤0.01% |
33,297
-1,335
| -4% | -$7.06K |
|
4943
Pure Cycle
PCYO
$253M
| $172K | ﹤0.01% |
15,598
+681
| +5% | +$6.76K |
|
|
AKTS
4944
DELISTED
Akoustis Technologies Inc
AKTS
| $171K | ﹤0.01% |
53,873
+2,715
| +5% | +$8.33K |
|
4945
Harvard Bioscience
HBIO
$27.5M
| $171K | ﹤0.01% |
3,119
+3,033
| +3,527% | +$166K |
|
4946
Alpha Tau Medical
DRTS
$1.06B
| $171K | ﹤0.01% |
39,180
-19,397
| -33% | -$69.5K |
|
4947
Cardlytics
CDLX
$21.7M
| $171K | ﹤0.01% |
2,705
-4,088
| -60% | -$248K |
|
4948
Immuneering
IMRX
$267M
| $170K | ﹤0.01% |
16,782
+15,752
| +1,529% | +$151K |
|
|
NRT
4949
North European Oil Royalty Trust
NRT
$87.4M
| $169K | ﹤0.01% |
+13,028
| New | +$175K |
|
4950
Norwood Financial Corp
NWFL
$370M
| $169K | ﹤0.01% |
5,723
-524
| -8% | -$14.4K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.